Molindra Health

Dr. David M Boruta

BS in Biology, Class of 1999, Fellowship in gynecologic oncology, Residency in Obstetrics and Gynecology

Oncologist

Registration listed: Texas Medical Board · 14278

Speaks English, Russian, Spanish

Report incorrect information

Practices

League City 77573, League City

Utmb Health League City Campus

2240 Gulf Fwy S, League City 77573, League City TX, Texas, United States of America (USA)

Office hours not listed

Fee not listed

Office hours are listed by the practice and are not appointment slots. Confirm fees, timings and address before visiting.

119 Services

  • Lung Cancer
  • Transitional cell carcinoma: a case-control study
  • Metastatic Respiratory System Cancer
  • liver biopsy
  • Intraoperative Radiation Therapy in the Management of Gynecologic Malignancies
  • Endometrial and ovarian cancer management
View all (119)
  • Hemophilia
  • Laparoscopic and robotic gynecologic surgeries
  • Minimally invasive management of the adnexal mass
  • Upper Digestive Tract Cancer
  • Cervix Carcinoma
  • Hysteroscopy
  • Endocrine Gland Cancer
  • Vulvectomy
  • Obstetrics & Gynecology
  • Endometrial stromal sarcoma: Clinicopathologic study of 29 patients
  • Thyroid Cancer
  • Coagulation Disorders
  • Destruction or Excision of Lesion of Cervix (incl. LEEP)
  • Duodenal Cancer
  • ANEMIA
  • Malignant Pleura Secondary
  • Cervical Cancer Treatment
  • Breast Cancer Screening
  • Urinary Tract Cancer
  • Excision of Cervix
  • Fallopian Tube Cancer
  • Male Breast Carcinoma
  • Pelvic malignancy procedures
  • Skin Cancer
  • Pleural Cancer
  • Hypothalamus Cancer
  • Laparoendoscopic single-site surgery in gynecologic oncology: An update
  • Thoracentesis
  • The outcome of laparoscopy versus laparotomy for the management of early stage cervical cancer
  • Gynecologic cancer treatment
  • Bladder Cancer Treatment
  • Secondary Malignancies
  • Oral Cancer Screening
  • Breast Cancer
  • Thyroid cancer Treatment
  • Adrenal Gland Cancer
  • Brain cancer
  • NeuroEndocrine Tumors
  • Gynecological Cancer Treatment
  • Pineal Region Tumors
  • skin cancer treatment
  • Laparoscopic management of pelvic masses in pregnancy
  • Colorectal Cancer
  • Breast Lump
  • Osteosarcoma Treatment
  • Lung Cancer Treatment
  • Endometrial cancer: A comprehensive review and current management strategies
  • Cancer Screening
  • Malignant Pituitary Gland Tumor
  • Acute Myeloid Leukemia
  • Colporrhaphy
  • Small Intestine Cancer
  • Colon Cancer
  • Acute Leukemia
  • Liver Cancer
  • Destruction or Excision of Vaginal Lesions
  • Ovarian Cancer
  • Ductal Carcinoma In Situ (DCIS) treatment
  • Surgical management of pelvic masses in pregnancy
  • Laparotomy
  • Biliary Tract Cancer
  • Anal and Rectal Cancer
  • Skin Screenings
  • Uterine Carcinoma
  • Neutropenia
  • Laparoscopic Hysterectomy
  • Myeloproliferative Disorders
  • Uterine Cancer
  • Gynecologic Cancer
  • Stomach and Small Intestine Cancer
  • Anemia Treatment
  • Labia Majora Cancer
  • Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer
  • Liver cancer Treatment
  • Cadaveric lab: Advanced pelvic anatomy and hysterectomy
  • Retroperitoneum Cancer
  • development and incorporation of minimally invasive surgical techniques in women with gynecologic cancers
  • Salpingo Oopherectomy
  • Vulvar Cancer
  • Laparoendoscopic single-site radical parametrectomy for treatment of cervix cancer diagnosed after simple hysterectomy
  • Osteosarcoma
  • Vaginal Cancer Treatment
  • Mantle Cell Lymphoma
  • Urethra Cancer
  • bone cancer treatment
  • Colposcopy
  • Vulvovaginal Rhabdomyosarcoma
  • Laparoscopy Compared With Laparotomy for Debulking Ovarian Cancer After Neoadjuvant Chemotherapy
  • Management of vascular injury: when to open and when to call for help
  • Peritoneal Cancer
  • Ductal Carcinoma in Situ
  • Cervical Cancer
  • Breast Lump Treatment
  • Non-Hodgkin's Lymphoma
  • Multiple Myeloma
  • Vulvar Cancer Treatment
  • Laparoscopic surgical staging of early ovarian cancer
  • Tissue extraction methods: alternatives to mechanical morcellation
  • Soft Tissue Sarcoma
  • Breast Carcinoma
  • Gynecologic Oncology
  • Salpingectomy with Robotic Assist
  • Laparoscopic staging for apparent stage I epithelial ovarian cancer
  • Open Hysterectomy
  • Step-by-step TLH avoiding the pitfalls
  • Pleura Cancer
  • Endocervical Curettage
  • Minimally Invasive Gynecologic Procedures
  • Ovarian Cancer Treatment
  • Uterine Cancer Treatment
  • Bladder Cancer
  • Bone Cancer
  • Vaginal Cancer

Education

  • BS in Biology — University of Michigan, 1992
  • Class of 1999 — University of Milan Medical School, 1996
  • Fellowship in gynecologic oncology — University of North Carolina Hospitals, 2003
  • Residency in Obstetrics and Gynecology — Massachusetts General Hospital GYN, 2000

Registrations

  • 14278 · Texas Medical Board
  • 1699729236 · National Provider Identifier (NPI)

Languages

English, Russian, Spanish

Is any information incorrect?

Help us keep this profile accurate. Our team reviews every report before anything changes.

Are you Dr. David M Boruta? Claim this profile to confirm it is you and keep it up to date.